- Home
- RDGT vs GOVX Comparison
RDGT vs GOVX Comparison
Compare RDGT & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDGT
- GOVX
- Stock Information
- Founded
- RDGT N/A
- GOVX 2001
- Country
- RDGT China
- GOVX United States
- Employees
- RDGT N/A
- GOVX N/A
- Industry
- RDGT
- GOVX Biotechnology: Pharmaceutical Preparations
- Sector
- RDGT
- GOVX Health Care
- Exchange
- RDGT NYSE
- GOVX Nasdaq
- Market Cap
- RDGT 6.4M
- GOVX 7.6M
- IPO Year
- RDGT N/A
- GOVX N/A
- Fundamental
- Price
- RDGT $1.30
- GOVX $0.79
- Analyst Decision
- RDGT
- GOVX Strong Buy
- Analyst Count
- RDGT 0
- GOVX 4
- Target Price
- RDGT N/A
- GOVX $10.50
- AVG Volume (30 Days)
- RDGT 61.5K
- GOVX 2.8M
- Earning Date
- RDGT 08-05-2025
- GOVX 07-28-2025
- Dividend Yield
- RDGT N/A
- GOVX N/A
- EPS Growth
- RDGT N/A
- GOVX N/A
- EPS
- RDGT N/A
- GOVX N/A
- Revenue
- RDGT $147,126,392.00
- GOVX $5,591,576.00
- Revenue This Year
- RDGT N/A
- GOVX N/A
- Revenue Next Year
- RDGT N/A
- GOVX N/A
- P/E Ratio
- RDGT N/A
- GOVX N/A
- Revenue Growth
- RDGT N/A
- GOVX N/A
- 52 Week Low
- RDGT $0.72
- GOVX $0.43
- 52 Week High
- RDGT $4.50
- GOVX $11.18
- Technical
- Relative Strength Index (RSI)
- RDGT N/A
- GOVX 49.37
- Support Level
- RDGT N/A
- GOVX $0.60
- Resistance Level
- RDGT N/A
- GOVX $0.88
- Average True Range (ATR)
- RDGT 0.00
- GOVX 0.08
- MACD
- RDGT 0.00
- GOVX 0.03
- Stochastic Oscillator
- RDGT 0.00
- GOVX 68.40
About RDGT RIDGETECH INC
Ridgetech Inc formerly China Jo-Jo Drugstores Inc is a retailer and distributor of pharmaceutical products. The company's operating segments include Retail drugstores, Online Pharmacy, and Drug wholesale. Retail drugstores segment sells prescription and over-the-counter medicines, TCM, dietary supplements, medical devices, and sundry items to retail customers. The online pharmacy segment sells drugs through third-party platforms such as Alibaba's Tmall, JD.com, and Amazon.com. It generates maximum revenue from the Retail drugstores segment.
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.